Gemcitabine hydrochloride oral formulation (D07001-F4)
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for Gemcitabine hydrochloride oral formulation (D07001-F4), covering 2016-09-02 to 2016-09-02. Get the full timeline:
Most recent: Clinical Trial Update: An Exploratory Study of Gemcitabine Hydrochloride Oral Formulation (D07001-F4) in Subjects With Malignant Tumors [EARLY_Phase 1]